Held : No
The assessee dealers were purchasing BSNL postpaid/prepaid
cellular sim card on which full tax had been paid by BSNL.
The Service Tax department proceeded against the dealers
and the issued show cause notice. The dealers contended that they are only
distributor appointed by BSNL, they are not clients and they are not carrying
on any activity of service. They further contended that they are buying and
selling sim card, which are goods and the difference is treated as profit or
loss.
The Tribunal concluded that the dealers were not caring on
the activity, liable to the tax under business service. The dealer has not
rendered any service but has actually done the activity of purchases and sale
of goods on which no service taxes is leviable. Finally they noted that since
BSNL had already discharged their tax burden, there cannot be double taxation.
[South East Corporation vs. C.C. Coaching (Tri. - Bang.)] 8
STR
Held – No.
The issue in these appeals related to valuation of
medicament under the Central Excise Act being manufactured and cleared in a
situation of loan licence arrangement as per Drugs and Cosmetics Act, 1940,
wherein raw materials and packaging materials are supplied by one holding the
loan licence or a loan licensee under the Drugs and Cosmetics Act, 1940 and
the medicaments are manufactured at the premises of another manufacturer
(hereinafter referred to for ease of reference as ‘job worker’).
25 Show Cause Notices which were issued against the
different notices by the Commissioner of Central Excise, Goa and 7 notices
were issued by Directorate General of Central Excise Intelligence, Bangalore
Zone Unit and they were disposed by a common order, as it was found that the
issues in the notices and the defence replies submitted was similar. The
Commissioner, after considering the submissions found:
-
The loan licensees possess a
loan license under the Drugs and Cosmetics Act, which authorizes them to
manufacture for sale and distribution at other location.
-
The application made for loan
license, proposal by the loan licensee to the job worker and consent letters
by the job workers indicate that medicaments are to be manufactured by loan
licensee with their own raw materials and packaging materials at the factory
of the job worker by taking on loan the premises, equipment, staff and
testing facilities of the job worker by taking on loan the premises,
equipment, staff and testing facilities of the job worker.
-
The job workers, per the
agreement and authorization from loan licensee, discharged Central Excise
formalities like filling classification and price declaration, statutory
returns and records. All the records in respect of the “Said Medicaments”
except the Central Excise statutory records were maintained on loan
licensee’s account.
-
The Batch Manufacturing
Records maintained by the job worker indicate that, all the Raw Materials /
Packaging Materials required for manufacture of the “Said Medicaments” are
procured from Raw Materials / Packaging Materials stores in the production
department under cover of Raw/ Packaging Material Notes issued on account of
the loan licensee for manufacture on the loan licensee’s account
-
The job worker did not
possess a drug manufacturing licence for said medicaments. Thus the job
worker was not permitted to manufacture the “Said Medicaments”, though under
the said Drugs & Cosmetics Act and Rules they can make their facilities
available to a holder of valid loan licensee.
-
The clause of agreement
between loan licensee and job worker were not found true to facts. The
factual position was that the job worker did not possess the drug licence
for the manufacture of the said medicaments, that the manufacturing licence
was held by the loan licensee, that the said medicaments were manufactured
on account of loan licensee taking infrastructure of job worker on loan and
all the documents were maintained by the job worker on licensee’s account.
The loan licensee who were referred to as the “Marketing Company” in the
said agreement did not possess any other licence from any “Licensing
Authority” to sell or distribute in wholesale the “Said Medicaments” except
the loan licence to manufacture for sale or distribute the “Said
Medicaments”.
-
All raw materials and
packaging materials were supplied by the loan licensee and the job worker
did not use any raw material or packaging material of their own. The same
was always under the ownership of loan licensee and even hypothecated to the
banks and insured by the loan licensee.
-
The packaging and labels of
the medicaments clearly show the loan license as the manufacturer at the
location of the job workers factory and it does not contain any mention of
the name of the job worker.
-
The balance sheets of both
job workers and loan licensee reveal that it is not the job worker but the
loan licensee, who have shown these medicaments in their accounts as
produced and sold by them.
And the definition of manufacture under section 2(f) of the
Central Excise Act, 1944 that the loan licensee was to be treated as
manufacturer by the licensing authority under the Drugs and Cosmetics Act,
1940 in terms of the definition and the responsibility in respect of quality
etc. lies with the loan licensee.
Once the Commissioner (Appeals) held that the loan licensee
would be treated as manufacturer, the question of assessable value of the
medicament manufactured by the loan licensee on the job workers premises was
to be viewed in the light of section 4 of the Central Excise Act, 1944 read
with the Valuation Rules and found that in the facts and circumstances of the
job worker was not an independent processor. Therefore, the decision in the
case of Ujjagar Prints 38 ELT 535 (SC) was not applicable.
In view of his findings, he held that the duty demand on
the job worker does not stand and the demand of duty will have to be made on
the loan licensee.
The two members of Tribunal deferred on the decision. The
technical member felt that job workers only is manufacturer whereas and
judicial member felt that loan licensor was manufacturer.
The matter was referred to third member. He observed that
great reliance has been placed by Member (Technical) on the decision of the
Gujarat High Court in the case of Indica Laboratories Pvt. Ltd and therefore
it would be useful to look the ratio of this decision which reads as under:
“It has been held that loan licensees are also
manufacturer, within the meaning of the term as envisaged by the said Act and
the Rules and specially when they get their goods manufactured under their own
control or supervision and out of their own raw material at the factory
premises belonging to someone else also and such premises they might have
hired for the time being, shift wise or otherwise”.
This is the key test laid down by the Hon’ble High Court as
one of control and supervision. The agreement entered into by the appellants
does clearly shows that there is hire of the factory shift-wise or any wise.
In view of this, the loan licensee cannot be held to be manufacturer.
It was submitted that above test was recognized and was
confirmed by a Larger bench of the Tribunal in Lupin Laboratories vs.
Commissioner wherein it was categorically held, inter alia, by the Tribunal
that “since there is no evidence on record that the respondents had hired any
shift or shifts in the factory of M/s Jay Chem Products for carrying out the
manufacture of the disputed goods under their own supervision and control on
the ratio of judgment quoted above they cannot be deemed as the manufacturers
of the goods in question. Under these circumstances, even though the
respondents had supplied the major production of raw materials and packaging
material and also exercised some supervision and control over the
manufacturing activities, M/s. Jay Chem Products who actually carried out the
manufacturing activity in their factory as job worker have to be deemed as the
manufacturers of the goods.
They referred to the various clauses of the agreement
entered into between job worker and the loan licensee which makes it clear
that the job workers were independently, carrying out the manufacture of said
medicaments at their premises and were in fact responsible for ensuring that
the said medicines confirm to the prescribed quality of standards as also
applicable laws. Clause 3 of the agreement states that the manufacturer shall
follow technical and scientific data, prescription and advice so given or that
may be given hereafter for use of raw material and auxiliary substances,
manufacturing, processing and/or finishing the product and shall conform to
the same. Clause 7 states that manufacturer shall allow duly authorized
representative/ representatives of the Marketing Company to inspect at any
time manufacture of the product and the methods of manufacturing, processing
and/or finish and shall supply at the request of the representative/
representatives sample of the product. The manufacturer shall be primarily
responsible to ensure that the batches of products so manufactured,
processed…. are in accordance with the process/processes,
specification/specifications… of marketing company, since the control over
production is entirely exercised by him. Clause 17 states that manufacturer
will be entitled to charge towards processing and/or manufacturing charges
which will include cost of production plus his profit for the services as
herein provided as the rate/rates as mentioned in Schedule A.
These clauses clearly show that the job worker is not
working in the supervision and control of loan licensee and that the loan
licensee has not hired the premises of job worker either shift-wise or any
wise and that the manufacturer charges per unit manufactured at the rates
specified in Schedule A.
I find that the agreement between the loan licensee and the
job worker is very clear that the supervision and control will be that of the
job worker only and as in every job work, the manufacture has to be carried
out as per the price indicated by the raw material supplier and as per the
specifications laid down by the raw material supplier and raw material
supplier has a right to inspect and draw sample at each stage to ensure that
the standards prescribed by him are being followed especially so in the case
of drugs where he ultimately has to be held liable for any deficiency in
quality where the human lives are involved. No evidence has been brought out
to show that the premises had been hired on a shifts basis or otherwise and on
the contrary, the agreement clearly shows that the manufacturing charges will
be paid at the rate specified in the Schedule on the basis of per unit and
there is no reference to payment on the basis of any shift or any particular
period.
I am, therefore, of the view that the matter is fully
covered by the Larger Bench decision of the Tribunal in the Lupin Laboratories
case cited supra and followed in subsequent judgments by the Tribunal. I am
therefore in agreement with the views expressed by learned Member (Technical)
Shri S.S. Sekhon. The reference is accordingly answered that appeals are to be
allowed as held by Member (Technical).
Thus it was held that only job worker can be treated as
manufacturer u/s 2(f) of the Central Excise Act.
Cosme Remedies vs. CCE 2003 ELT 567 [Tri-Mum (TM)]